Predictors of insufficient recanalization and portal hypertensive complications after treatment of non-cirrhotic, non-malignant portal vein thrombosis – a population-based study

References

• Manzano-Robleda MDC, Barranco-Fragoso B, Uribe M, et al. Portal vein thrombosis: what is new? Ann Hepatol. 2015;14(1):20–27.
   PubMed Web of Science ®Google Scholar
• Lang SA, Loss M, Wohlgemuth WA, et al. Clinical management of acute portal/mesenteric vein thrombosis. Viszeralmedizin. 2014;30(6):394–400.
   PubMedGoogle Scholar
• Sogaard KK, Astrup LB, Vilstrup H, et al. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7(1):34.
   PubMedGoogle Scholar
• Handa P, Crowther M, Douketis JD. Portal vein thrombosis. Clin Appl Thromb Hemost. 2014;20(5):498–506.
   PubMed Web of Science ®Google Scholar
• Turnes J, García-Pagán JC, González M, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6(12):1412–1417.
   PubMed Web of Science ®Google Scholar
• Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51(1):210–218.
   PubMed Web of Science ®Google Scholar
• Condat B, Pessione F, Helene Denninger M, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32(3):466–470.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Castro KI, Vitale A, Fadin M, et al. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis. Eur J Gastroenterol Hepatol. 2019;31(1):34–42.
   PubMed Web of Science ®Google Scholar
• Rosenqvist K, Eriksson LG, Rorsman F, et al. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiol. 2016;57(5):572–579.
   PubMed Web of Science ®Google Scholar
• De Santis A, Moscatelli R, Catalano C, et al. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study. Dig Liver Dis. 2010;42(6):451–455.
   PubMedGoogle Scholar
• Hollingshead M, Burke CT, Mauro MA, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16(5):651–661.
   PubMed Web of Science ®Google Scholar
• Semiz-Oysu A, Keussen I, Cwikiel W. Interventional radiological management of prehepatic obstruction of the splanchnic venous system. Cardiovasc Intervent Radiol. 2007;30(4):688–695.
   PubMed Web of Science ®Google Scholar
• Ganger DR, Klapman JB, McDonald V, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for budd-chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol. 1999;94(3):603–608.
   PubMed Web of Science ®Google Scholar
• Klinger C, Riecken B, Schmidt A, et al. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Dig Liver Dis. 2017;49(12):1345–1352.
   PubMedGoogle Scholar
• Gerwing M, Wilms C, Heinzow H, et al. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol. 2019;31(12):1584–1591.
   PubMed Web of Science ®Google Scholar
• Liu K, Li W, Du X, et al. Comparison of systemic thrombolysis versus indirect thrombolysis via the superior mesenteric artery in patients with acute portal vein thrombosis. Ann Vasc Surg. 2017;39:264–269.
   PubMed Web of Science ®Google Scholar
• Rodrigues SG, Sixt S, Abraldes JG, et al. Systematic review with meta‐analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther. 2019;49(1):20–30.
   PubMed Web of Science ®Google Scholar
• Wang C, Wei L, Niu H, et al. Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis. WJG. 2018;24(39):4482–4488.
   PubMed Web of Science ®Google Scholar
• Wolter K, Decker G, Kuetting D, et al. Interventional treatment of acute portal vein thrombosis. Rofo. 2018;190(8):740–746.
   PubMedGoogle Scholar
• European Association For The Study Of The Liver. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2015;64(1):179–202.
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352.
   PubMed Web of Science ®Google Scholar
• Tilsed JVT, Casamassima A, Kurihara H, et al. ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg. 2016;42(2):253–270.
   PubMed Web of Science ®Google Scholar
• Luo J, Yan Z, Wang J, et al. Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach. J Vasc Interv Radiol. 2011;22(1):61–69.
   PubMed Web of Science ®Google Scholar
• Hall TC, Garcea G, Metcalfe M, et al. Impact of anticoagulation on outcomes in acute non-cirrhotic and non-malignant portal vein thrombosis: a retrospective observational study. Hepatogastroenterology. 2013;60(122):311–317.
   PubMedGoogle Scholar
• Maurice JB, Brodkin E, Arnold F, et al. Validation of the baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65(5):899–905.
   PubMed Web of Science ®Google Scholar
• Sarin S, Philips CA, Kamath P, et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology. 2016;151(4):574–577.
   PubMed Web of Science ®Google Scholar
• Björck M, Koelemay M, Acosta S, et al. Editor's choice - management of the diseases of mesenteric arteries and veins: clinical practice guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53:460–451.
   PubMed Web of Science ®Google Scholar